Insulin Lispro (Humalog) from Japan
Insulin lispro is a rapid-acting insulin analogue created by recombinant DNA technology with amino acid modifications for faster absorption. As a structural analogue of insulin used primarily as a hormone, it is classified under tariff item 2937.12.00.
Duty Rate — Japan → Canada
0%
Import Tips
• Provide evidence of the product's insulin analogue status, including amino acid sequence information
• Import as bulk API to maintain classification under Chapter 29
• Check if a Drug Identification Number is required for the finished product